e-Article
Preclinical Development of EDIT301, an Autologous Cell Therapy Comprising AsCas12a-RNP Modified Mobilized Peripheral Blood-CD34 (+) Cells for the Potential Treatment of Transfusion Dependent Beta Thalassemia
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15280020